HERBALIFE LTD's ticker is HLF and the CUSIP is G4412G101. A total of 217 filers reported holding HERBALIFE LTD in Q1 2023. The put-call ratio across all filers is 3.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $6 | -99.9% | 115 | +9.5% | 0.00% | – |
Q3 2022 | $7,000 | +16.7% | 105 | +22.1% | 0.00% | – |
Q2 2022 | $6,000 | -33.3% | 86 | -26.5% | 0.00% | – |
Q1 2022 | $9,000 | +800.0% | 117 | +3800.0% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 3 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | -94.7% | 3 | -99.2% | 0.00% | – |
Q2 2021 | $19,000 | – | 372 | +12300.0% | 0.00% | – |
Q1 2021 | $0 | – | 3 | 0.0% | 0.00% | – |
Q4 2020 | $0 | -100.0% | 3 | -83.3% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 18 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 18 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 18 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 18 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | -85.7% | 18 | -84.9% | 0.00% | – |
Q4 2018 | $7,000 | +40.0% | 119 | +32.2% | 0.00% | – |
Q2 2018 | $5,000 | +66.7% | 90 | +83.7% | 0.00% | – |
Q1 2018 | $3,000 | 0.0% | 49 | 0.0% | 0.00% | – |
Q4 2017 | $3,000 | 0.0% | 49 | 0.0% | 0.00% | – |
Q3 2017 | $3,000 | 0.0% | 49 | +28.9% | 0.00% | – |
Q2 2017 | $3,000 | +50.0% | 38 | 0.0% | 0.00% | – |
Q1 2017 | $2,000 | -71.4% | 38 | -72.5% | 0.00% | – |
Q4 2016 | $7,000 | -22.2% | 138 | 0.0% | 0.00% | – |
Q3 2016 | $9,000 | -71.9% | 138 | -74.8% | 0.00% | -100.0% |
Q2 2016 | $32,000 | +10.3% | 548 | +0.4% | 0.00% | 0.0% |
Q4 2015 | $29,000 | – | 546 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BlueDrive Global Investors LLP | 850,028 | $25,807,000 | 11.41% |
Alua Capital Management LP | 5,353,223 | $162,524,000 | 11.12% |
Route One Investment Company, L.P. | 10,043,232 | $304,913,000 | 9.50% |
Bronte Capital Management Pty Ltd. | 2,962,635 | $89,946,000 | 7.56% |
WINDACRE PARTNERSHIP LLC | 10,003,500 | $303,706,000 | 6.38% |
CAS Investment Partners, LLC | 2,907,762 | $88,280,000 | 5.91% |
Deccan Value Investors L.P. | 3,062,839 | $92,988,000 | 4.74% |
JABODON PT CO | 170,332 | $5,171,000 | 2.35% |
683 Capital Management, LLC | 1,440,597 | $43,737,000 | 2.34% |
Patient Capital Management, LLC | 194,300 | $5,899,000 | 2.00% |